Nobel Biocare has expanded its trusted zygomatic solutions with the launch of the new NobelZygoma TiUltra implant system. For cases of severe maxillary resorption, Nobel Biocare’s zygomatic implants offer an immediate protocol with graftless treatment, designed to significantly shorten the time to teeth for increased patient satisfaction.

Incorporating the TiUltra surface, the latest implants are designed to promote soft tissue health, enhance implant stability, and minimise complications. The expanded product range also offers greater surgical and prosthetic flexibility, allowing clinicians to choose from an extensive selection of implant lengths. Multi-unit abutments with the anodised Xeal surface are available in a variety of gingival heights. Additionally, more reference markings have been added to improve handling and usability.

Supported by over 25 years of clinical experience, Nobel Biocare zygomatic implants demonstrate remarkable long-term outcomes. One study reports an average survival rate of 96.1% after more than ten years.¹ To support professionals seeking to excel in zygomatic treatments, Nobel Biocare also offers the Zygoma Academy, which provides one-on-one mentorship, study clubs and hands-on training.

More information can be found at www.nobelbiocare.com.

Reference

1. Davó R, Syed H, Vicent VG, Pons O. Clinical outcome of 33 immediately loaded NobelZygoma 45° (new design) [PSA‐358]. Clin Oral Implants Res. 2016 Sep;27 Suppl 13:256. doi: 10.1111/clr.254_12958.

Nobel Biocare Zygoma Academy Zygomatic implants Dental implantology